Breaking

Archive

Dec 1 result
19:05
19:05

Researchers Studying New PrEP Drug in HIV Vaccine Trial HIV vaccine trials 4

Dr Eugene Ruzagira, a member of the team of researchers told a news conference organized by the Health Journalists Network that they are giving all the participants in their PrEPVACC trial a daily Descovy tablet to assess whether it’s effective in preventing participants from getting infected.
Dec 1 result